AgingResearch.News
NAD+ & sirtuinsAnimalsPeer-reviewed

Macrophage CD38 drives age-related placental senescence by depleting NAD+

Targeting CD38 or supplementing NAD+ precursors reduces placental aging and improves offspring metabolic health in models of delayed maternal age.

Nature communications · Hua L et al. · Paper published 27 Aug 2026

Paper

In humans, mice, and pigs, aged placentas exhibit increased macrophage CD38 expression and NAD+ deficiency. Researchers used metabolomics, single-cell RNA sequencing, and spatial transcriptomics to map these conserved features during reproductive aging. Through genetic and pharmacological tests, the team found that CD38 on macrophages depletes NAD+ in neighboring decidual stromal cells, accelerating placental senescence. This CD38 rise is triggered by early-onset inflammation and senescence-associated secretory phenotype activity through the IRF5 pathway. Administering CD38 inhibitors or NAD+ precursors attenuated placental senescence, rescued intrauterine growth restriction, and improved long-term metabolic health in offspring.

Why it matters

The study directly links immune-mediated NAD+ depletion to tissue aging in the placenta. It also highlights CD38 inhibition as a therapeutic concept for age-related reproductive and developmental complications.

Caveats

Although molecular profiling included human tissue, interventional rescue experiments were conducted in animal models. The abstract does not report clinical trials or safety profiles for these interventions during human pregnancy.

Written from the paper’s abstract, and every claim checked against it before publishing. Read the paper for the full methods and data.

The paper

CD38-activated macrophages drive age-related placental senescence by depleting NAD⁺ in decidual stromal cells

Hua L, Yang X, Gao D et al.

Nature communications · 27 Aug 2026 · Peer-reviewed

Relevance
Core geroscience
News value
Important
Evidence
Animals
Status
Peer-reviewed
See all